BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2014
View Archived Issues
One Lambda licenses HLA primer technology from GenoDive Pharma
Read More
NIAID grant supports TB drug development at Microbiotix
Read More
Yabao and Lilly partner on glucokinase activator in China
Read More
Once-daily tofacitinib shows bioequivalence for the immediate-release formulation
Read More
Mariel Therapeutics to acquire Stryker's BMP-7 assets
Read More
Arrien Pharmaceuticals prepares new SIK-2 inhibitors
Read More
Researchers at AbbVie synthesize novel PKC inhibitors for autoimmune diseases
Read More
New orexin receptor antagonists reported by Taisho Pharmaceutical
Read More
Takeda Pharmaceutical synthesizes new CH24H inhibitors
Read More
Enrollment begins in phase I trial of TPI-287 in rare tauopathy diseases
Read More
Genmab achieves third milestone in daratumumab collaboration
Read More
Novel lipidated NMU analogues with promise for suppressing food intake in vivo
Read More
Cellceutix patents novel agents for bacterial and other infections
Read More
Patient enrollment completed in phase II trial of carboplatin, paclitaxel and Reolysin
Read More
Biotie awarded Michael J. Fox Foundation grant for a clinical study of SYN-120
Read More
Merck & Co. discloses new BACE inhibitors for Alzheimer's disease
Read More
Portola Pharmaceuticals and Daiichi Sankyo form second collaboration
Read More
Eagle Pharmaceuticals' bendamustine hydrochloride product receives orphan drug status
Read More
Avraham Pharmaceuticals reports interim data from phase IIb study of ladostigil
Read More
Cesca Therapeutics discusses pivotal trial for CLIRST with FDA
Read More
FDA approves Kerydin for onychomycosis
Read More
Promising phase II and III results for a number of novel oncolytics presented at ASCO
Read More
Japanese approval of Jakavi triggers milestone payment to Incyte
Read More
InSite Vision plans NDA filing for DexaSite next year
Read More
CardioCell initiates phase II trial of allogeneic stem cell therapy for chronic heart failure
Read More